Annual EBITDA
$446.10 M
-$13.90 M-3.02%
December 31, 2023
Summary
- As of February 7, 2025, SGRY annual EBITDA is $446.10 million, with the most recent change of -$13.90 million (-3.02%) on December 31, 2023.
- During the last 3 years, SGRY annual EBITDA has risen by +$168.30 million (+60.58%).
- SGRY annual EBITDA is now -3.02% below its all-time high of $460.00 million, reached on December 31, 2022.
Performance
SGRY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$111.10 M
-$8.50 M-7.11%
September 30, 2024
Summary
- As of February 7, 2025, SGRY quarterly EBITDA is $111.10 million, with the most recent change of -$8.50 million (-7.11%) on September 30, 2024.
- Over the past year, SGRY quarterly EBITDA has dropped by -$8.50 million (-7.11%).
- SGRY quarterly EBITDA is now -19.20% below its all-time high of $137.50 million, reached on December 31, 2021.
Performance
SGRY Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$472.90 M
-$400.00 K-0.08%
September 30, 2024
Summary
- As of February 7, 2025, SGRY TTM EBITDA is $472.90 million, with the most recent change of -$400.00 thousand (-0.08%) on September 30, 2024.
- Over the past year, SGRY TTM EBITDA has dropped by -$400.00 thousand (-0.08%).
- SGRY TTM EBITDA is now -0.59% below its all-time high of $475.70 million, reached on March 31, 2024.
Performance
SGRY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SGRY EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -3.0% | -7.1% | -0.1% |
3 y3 years | +60.6% | -19.2% | +17.9% |
5 y5 years | +207.2% | -19.2% | +17.9% |
SGRY EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -3.0% | +11.3% | -19.2% | +38.7% | -0.6% | +17.9% |
5 y | 5-year | -3.0% | +60.6% | -19.2% | +160.8% | -0.6% | +90.7% |
alltime | all time | -3.0% | +651.2% | -19.2% | +223.8% | -0.6% | +2002.8% |
Surgery Partners EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $111.10 M(-7.1%) | $472.90 M(-0.1%) |
Jun 2024 | - | $119.60 M(+9.0%) | $473.30 M(-0.5%) |
Mar 2024 | - | $109.70 M(-17.2%) | $475.70 M(+6.6%) |
Dec 2023 | $446.10 M(-3.0%) | $132.50 M(+18.8%) | $446.10 M(+2.0%) |
Sep 2023 | - | $111.50 M(-8.6%) | $437.40 M(+1.8%) |
Jun 2023 | - | $122.00 M(+52.3%) | $429.80 M(+4.2%) |
Mar 2023 | - | $80.10 M(-35.3%) | $412.30 M(-10.4%) |
Dec 2022 | $460.00 M(+14.7%) | $123.80 M(+19.2%) | $460.00 M(-2.9%) |
Sep 2022 | - | $103.90 M(-0.6%) | $473.70 M(+3.3%) |
Jun 2022 | - | $104.50 M(-18.2%) | $458.60 M(+4.5%) |
Mar 2022 | - | $127.80 M(-7.1%) | $438.80 M(+9.4%) |
Dec 2021 | $401.00 M(+44.3%) | $137.50 M(+54.8%) | $401.00 M(+4.1%) |
Sep 2021 | - | $88.80 M(+4.8%) | $385.30 M(+13.6%) |
Jun 2021 | - | $84.70 M(-5.9%) | $339.10 M(+5.1%) |
Mar 2021 | - | $90.00 M(-26.1%) | $322.50 M(+16.1%) |
Dec 2020 | $277.80 M(-10.4%) | $121.80 M(+185.9%) | $277.80 M(+12.0%) |
Sep 2020 | - | $42.60 M(-37.4%) | $248.00 M(-12.3%) |
Jun 2020 | - | $68.10 M(+50.3%) | $282.80 M(-2.2%) |
Mar 2020 | - | $45.30 M(-50.8%) | $289.30 M(-6.7%) |
Dec 2019 | $310.00 M | $92.00 M(+18.9%) | $310.00 M(+68.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2019 | - | $77.40 M(+3.8%) | $184.10 M(+9.1%) |
Jun 2019 | - | $74.60 M(+13.0%) | $168.70 M(+9.3%) |
Mar 2019 | - | $66.00 M(-294.7%) | $154.30 M(+6.3%) |
Dec 2018 | $145.20 M(-37.5%) | -$33.90 M(-154.7%) | $145.20 M(-18.9%) |
Sep 2018 | - | $62.00 M(+3.0%) | $179.10 M(+52.9%) |
Jun 2018 | - | $60.20 M(+5.8%) | $117.10 M(+10.4%) |
Mar 2018 | - | $56.90 M(+15.8%) | $106.06 M(-54.2%) |
Jun 2017 | - | $49.16 M(-10.0%) | $231.55 M(-4.7%) |
Mar 2017 | - | $54.59 M(-30.9%) | $243.05 M(+4.6%) |
Dec 2016 | $232.30 M(+291.2%) | $78.97 M(+61.7%) | $232.30 M(+265.5%) |
Sep 2016 | - | $48.83 M(-19.5%) | $63.55 M(-6.0%) |
Jun 2016 | - | $60.65 M(+38.3%) | $67.61 M(+19.8%) |
Mar 2016 | - | $43.85 M(-148.8%) | $56.42 M(-5.0%) |
Dec 2015 | $59.39 M(-9.8%) | -$89.78 M(-269.8%) | $59.39 M(-60.9%) |
Sep 2015 | - | $52.88 M(+6.9%) | $152.00 M(+25.0%) |
Jun 2015 | - | $49.47 M(+5.7%) | $121.61 M(+68.6%) |
Mar 2015 | - | $46.81 M(+1550.1%) | $72.14 M(+184.8%) |
Dec 2014 | $65.87 M(-5.8%) | $2.84 M(-87.4%) | $25.33 M(+12.6%) |
Sep 2014 | - | $22.49 M | $22.49 M |
Dec 2013 | $69.89 M(-2.5%) | - | - |
Dec 2012 | $71.66 M | - | - |
FAQ
- What is Surgery Partners annual EBITDA?
- What is the all time high annual EBITDA for Surgery Partners?
- What is Surgery Partners annual EBITDA year-on-year change?
- What is Surgery Partners quarterly EBITDA?
- What is the all time high quarterly EBITDA for Surgery Partners?
- What is Surgery Partners quarterly EBITDA year-on-year change?
- What is Surgery Partners TTM EBITDA?
- What is the all time high TTM EBITDA for Surgery Partners?
- What is Surgery Partners TTM EBITDA year-on-year change?
What is Surgery Partners annual EBITDA?
The current annual EBITDA of SGRY is $446.10 M
What is the all time high annual EBITDA for Surgery Partners?
Surgery Partners all-time high annual EBITDA is $460.00 M
What is Surgery Partners annual EBITDA year-on-year change?
Over the past year, SGRY annual EBITDA has changed by -$13.90 M (-3.02%)
What is Surgery Partners quarterly EBITDA?
The current quarterly EBITDA of SGRY is $111.10 M
What is the all time high quarterly EBITDA for Surgery Partners?
Surgery Partners all-time high quarterly EBITDA is $137.50 M
What is Surgery Partners quarterly EBITDA year-on-year change?
Over the past year, SGRY quarterly EBITDA has changed by -$8.50 M (-7.11%)
What is Surgery Partners TTM EBITDA?
The current TTM EBITDA of SGRY is $472.90 M
What is the all time high TTM EBITDA for Surgery Partners?
Surgery Partners all-time high TTM EBITDA is $475.70 M
What is Surgery Partners TTM EBITDA year-on-year change?
Over the past year, SGRY TTM EBITDA has changed by -$400.00 K (-0.08%)